Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Phibro Animal Health (NasdaqGM:PAHC) Q2 2026 Earnings call February 05, 2026 09:00 AM ET Company ParticipantsDonnie Bendheim - EVP of Corporate Strategy and CEO DesignateEkaterina Knyazkova - Equity Research AssociateGlenn David - CFOJack Bendheim - Chairman, President, and CEOLarry Miller - COOLinda Bolduc - VP, Equity Research Healthcare ServicesConference Call ParticipantsNavann Ty - Lead Analyst for HealthcareNone - AnalystOperatorHello, and thank you for standing by. My name is Regina, and I will be yo ...

Phibro Animal Health (NasdaqGM:PAHC) Q2 2026 Earnings call February 05, 2026 09:00 AM ET Company ParticipantsDonnie Bendheim - EVP of Corporate Strategy and CEO DesignateEkaterina Knyazkova - Equity Research AssociateGlenn David - CFOJack Bendheim - Chairman, President, and CEOLarry Miller - COOLinda Bolduc - VP, Equity Research Healthcare ServicesConference Call ParticipantsNavann Ty - Lead Analyst for HealthcareNone - AnalystOperatorHello, and thank you for standing by. My name is Regina, and I will be yo ...

Phibro Animal Health (NasdaqGM:PAHC) Q2 2026 Earnings call February 05, 2026 09:00 AM ET Speaker4Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Phibro Animal Health Corporation Second Quarter 2026 conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during thi ...

Phibro Animal Health Corporation Financial Results Fiscal Year 2026 Second Quarter Ended December 31, 2025 Webcast and Conference Call February 5, 2026 February 5, 2026 Webcast and Conference Call Cautionary Statement Regarding Forward-Looking Statements U.S. toll-free +1.888.330.2022 International toll +1.365.977.0051 Conference ID: 3927884 Important Information Internet Posting of Information This communication contains forward-looking statements that are subject to risks and uncertainties, including with ...

Exhibit 99.1 COMMENTARY "This was a strong quarter for us, and I'm really proud of how our teams are executing around the world," stated Jack Bendheim, President and Chief Executive Officer. "We're seeing faster than expected uptake of our newly integrated MFA portfolio, which is already giving our results a real lift. At the same time, our nutritional specialty and vaccine offerings continue to deliver strong, sustained growth across key markets. With this momentum and the progress we're making across the ...

Table of Contents OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 Phibro Animal Health Corporation (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 Delaware 13- ...

The Zacks Medical - Products industry is grappling with a challenging operating environment due to the tariffs imposed by the United States on multiple trading partners, including China, Europe and India. The increasing tariff rates are hurting the margins of several medical device makers, including GE HealthCare, Baxter and Abbott.The medical device makers have faced a persistent rise in commodity and manufacturing costs post COVID-19, particularly in consumer-facing areas like Nutrition. Price hikes imple ...

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 ...